All In Biotech

Drug Trial Radar · NCT02822144

General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke

Last checked: Nov 20, 2026Latest source record: May 23, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 351 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

351

Actual

Start

Sep 29, 2016

Primary completion

Aug 2020

Study completion Aug 2020

Sponsor

Lead sponsor
Rennes University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 4, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

In France, the annual incidence rate of acute ischaemic stroke is around 150 000 patients, 65 % of whom keep long-term disability. Several multicentric randomized controlled trials have shown the benefit of a mechanical thrombectomy in the acute phase of ischaemic stroke on functional disability, compared to a medical treatment alone (thrombolysis). The timeliness of revascularisation is an essential factor of good prognosis. This intra-arterial treatment, associated with thrombolysis if applicable, is the reference treatment of large-vessel occlusion. The stillness of the patient is required to control the safety of the recanalization. Currently, either a general anesthesia or a sedation can be performed. Several studies have shown a trend to superiority of the sedation but none was conducted with a high level of proof methodology. The aim of our multicentric randomized controlled trial is to compare sedation and general anesthesia during intra-arterial thrombectomy for an acute ischaemic stroke in the anterior cerebral circulation. The main outcome will be the efficacy on the functional neurological prognosis at 3 months.

Conditions

  • Stroke

Interventions

  • EtomidateDrug

  • SuccinylcholineDrug

  • PropofolDrug

  • RemifentanilDrug

  • LidocaineDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Score on the modified Rankin scaleTime frame: 3 months

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Département d'anesthésie-réanimation - Hôpital de la Cavale Blanche, CHU de Brest

    Brest, France

  • Service d'anesthésie-réanimation - Fondation A. de Rothschild

    Paris, France

  • Fédération d'anesthésie-réanimation - Hôpital Pontchaillou, CHU de Rennes

    Rennes, France

  • Service d'anesthésie-réanimation 1 - Hôpital Bretonneau, CHU de Tours

    Tours, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.